A detailed history of Vanguard Group Inc transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,093,364 shares of STXS stock, worth $7.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,093,364
Previous 3,029,251 2.12%
Holding current value
$7.27 Million
Previous $5.51 Million 14.46%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.76 - $2.35 $112,838 - $150,665
64,113 Added 2.12%
3,093,364 $6.31 Million
Q2 2024

Aug 13, 2024

BUY
$1.73 - $3.2 $718,443 - $1.33 Million
415,285 Added 15.89%
3,029,251 $5.51 Million
Q1 2024

May 10, 2024

BUY
$1.74 - $3.16 $326,140 - $592,300
187,437 Added 7.72%
2,613,966 $6.82 Million
Q4 2023

Feb 14, 2024

BUY
$1.42 - $1.96 $345,484 - $476,866
243,299 Added 11.14%
2,426,529 $4.25 Million
Q3 2023

Nov 14, 2023

BUY
$1.42 - $1.84 $10,857 - $14,068
7,646 Added 0.35%
2,183,230 $3.45 Million
Q2 2023

Aug 14, 2023

SELL
$1.51 - $2.27 $12,632 - $18,990
-8,366 Reduced 0.38%
2,175,584 $3.33 Million
Q1 2023

May 15, 2023

BUY
$1.85 - $2.71 $121,528 - $178,022
65,691 Added 3.1%
2,183,950 $4.46 Million
Q4 2022

Feb 10, 2023

BUY
$1.55 - $2.38 $2,546 - $3,910
1,643 Added 0.08%
2,118,259 $4.38 Million
Q2 2022

Aug 12, 2022

SELL
$1.75 - $3.71 $544,171 - $1.15 Million
-310,955 Reduced 12.81%
2,116,616 $3.9 Million
Q1 2022

May 13, 2022

SELL
$3.11 - $6.63 $30,922 - $65,922
-9,943 Reduced 0.41%
2,427,571 $9.05 Million
Q4 2021

Feb 14, 2022

SELL
$5.14 - $6.84 $237,226 - $315,686
-46,153 Reduced 1.86%
2,437,514 $15.1 Million
Q3 2021

Nov 12, 2021

SELL
$5.34 - $9.87 $907,506 - $1.68 Million
-169,945 Reduced 6.4%
2,483,667 $13.4 Million
Q2 2021

Aug 13, 2021

BUY
$6.41 - $10.17 $17 Million - $27 Million
2,653,612 New
2,653,612 $25.6 Million

Others Institutions Holding STXS

About Stereotaxis, Inc.


  • Ticker STXS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,790,096
  • Market Cap $176M
  • Description
  • Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...
More about STXS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.